JPY 927.0
(-0.54%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 139.81 Billion JPY | -17.33% |
2022 | 169.13 Billion JPY | 2.36% |
2021 | 165.23 Billion JPY | 15.03% |
2020 | 143.64 Billion JPY | 4.4% |
2019 | 137.59 Billion JPY | 17.26% |
2018 | 117.34 Billion JPY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 38.16 Billion JPY | -9.33% |
2023 Q4 | 42.09 Billion JPY | 3.19% |
2023 FY | 139.81 Billion JPY | -17.33% |
2023 Q3 | 40.79 Billion JPY | 8.22% |
2023 Q2 | 37.69 Billion JPY | 0.8% |
2023 Q1 | 37.39 Billion JPY | -11.46% |
2022 Q3 | 45.89 Billion JPY | 7.06% |
2022 Q1 | 38.13 Billion JPY | -5.58% |
2022 Q4 | 42.23 Billion JPY | -7.96% |
2022 FY | 169.13 Billion JPY | 2.36% |
2022 Q2 | 42.86 Billion JPY | 12.4% |
2021 FY | 165.23 Billion JPY | 15.03% |
2021 Q1 | 39.79 Billion JPY | 5.9% |
2021 Q3 | 42.69 Billion JPY | 0.8% |
2021 Q2 | 42.35 Billion JPY | 6.45% |
2021 Q4 | 40.39 Billion JPY | -5.41% |
2020 FY | 143.64 Billion JPY | 4.4% |
2020 Q2 | 34.52 Billion JPY | 16.69% |
2020 Q1 | 29.58 Billion JPY | 0.0% |
2020 Q3 | 41.96 Billion JPY | 21.55% |
2020 Q4 | 37.57 Billion JPY | -10.45% |
2019 FY | 137.59 Billion JPY | 17.26% |
2018 FY | 117.34 Billion JPY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
DVx Inc. | 4.76 Billion JPY | -2834.557% |
Seikagaku Corporation | 16.87 Billion JPY | -728.459% |
Eiken Chemical Co., Ltd. | 16.72 Billion JPY | -736.038% |
Create Medic Co., Ltd. | 5.47 Billion JPY | -2452.215% |
Techno Medica Co., Ltd. | 5.1 Billion JPY | -2639.92% |
Rion Co., Ltd. | 14.33 Billion JPY | -875.57% |
Nihon Kohden Corporation | 108.56 Billion JPY | -28.785% |
Fukuda Denshi Co., Ltd. | 72.73 Billion JPY | -92.241% |
Japan Lifeline Co., Ltd. | 30.37 Billion JPY | -360.264% |
Japan Medical Dynamic Marketing, INC. | 14.76 Billion JPY | -847.14% |
3-D Matrix, Ltd. | 3.08 Billion JPY | -4430.162% |
CYBERDYNE Inc. | 2.39 Billion JPY | -5742.833% |